SMART-Approach Pancreatic Cancer Surveillance in Clinical Practice
DOI:
https://doi.org/10.69734/rz628c44Keywords:
Pancreatic cancer, Genetic Testing, surveillance, Early Detection, Early Detection of Cancer, early diagnosis, pathogenic variant , hereditary syndrome, hereditary cancer syndrome, high-riskAbstract
Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy with over 66,000 new cases in the United States in 2024.(1) The dismal 5-year survival rate of 12% is largely due to late-stage diagnosis.(2) However, early detection rates and improved outcomes may be possible by targeted approaches for high-risk individuals (HRI) with certain genetic and family risk factors for pancreatic cancer.(3-7) This article outlines a practical approach to PDAC surveillance in clinical settings, focusing on identifying and monitoring HRI for early PDAC. We synthesize current recommendations for surveillance (Table 1) and detail lifetime PDAC risk by gene, alongside associated cancers in major hereditary syndromes (Table 2), to guide physicians in optimizing early detection and management strategies.
References
National Cancer Institute. Pancreatic cancer. SEER Cancer Statistics Review. Retrieved February 3, 2025, from https://seer.cancer.gov/statfacts/html/pancreas.html
Siegel, R. L., Miller, K. D., Wagle, N. S., & Jemal, A. (2023). Cancer statistics, 2023. CA: a cancer journal for clinicians, 73(1), 17–48. https://doi.org/10.3322/caac.21763
Syngal, S., Brand, R. E., Church, J. M., Giardiello, F. M., Hampel, H. L., Burt, R. W., & American College of Gastroenterology (2015). ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes. The American journal of gastroenterology, 110(2), 223–263. https://doi.org/10.1038/ajg.2014.435
Aslanian, H. R., Lee, J. H., & Canto, M. I. (2020). AGA Clinical Practice Update on Pancreas Cancer Screening in High-Risk Individuals: Expert Review. Gastroenterology, 159(1), 358–362. https://doi.org/10.1053/j.gastro.2020.03.088
Sawhney, M. S., Calderwood, A. H., Thosani, N. C., Rebbeck, T. R., Wani, S., Canto, M. I., Fishman, D. S., Golan, T., Hidalgo, M., Kwon, R. S., Riegert-Johnson, D. L., Sahani, D. V., Stoffel, E. M., Vollmer, C. M., Jr, Qumseya, B. J., & Prepared by: ASGE STANDARDS OF PRACTICE COMMITTEE (2022). ASGE guideline on screening for pancreatic cancer in individuals with genetic susceptibility: summary and recommendations. Gastrointestinal endoscopy, 95(5), 817–826. https://doi.org/10.1016/j.gie.2021.12.001
Goggins, M., Overbeek, K. A., Brand, R., Syngal, S., Del Chiaro, M., Bartsch, D. K., Bassi, C., Carrato, A., Farrell, J., Fishman, E. K., Fockens, P., Gress, T. M., van Hooft, J. E., Hruban, R. H., Kastrinos, F., Klein, A., Lennon, A. M., Lucas, A., Park, W., Rustgi, A., … International Cancer of the Pancreas Screening (CAPS) consortium (2020). Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium. Gut, 69(1), 7–17. https://doi.org/10.1136/gutjnl-2019-319352
National Comprehensive Cancer Network. (2025). Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate (version 2.2025). Retrieved from https://www.nccn.org/professionals/physician_gls/pdf/genetics_bopp.pdf
Bean, L. J. H., Scheuner, M. T., Murray, M. F., Biesecker, L. G., Green, R. C., Monaghan, K. G., Palomaki, G. E., Sharp, R. R., Trotter, T. L., Watson, M. S., Powell, C. M., & ACMG Board of Directors (2021). DNA-based screening and personal health: a points to consider statement for individuals and health-care providers from the American College of Medical Genetics and Genomics (ACMG). Genetics in medicine : official journal of the American College of Medical Genetics, 23(6), 979–988. https://doi.org/10.1038/s41436-020-01083-9
Bean, L. J. H., Funke, B., Carlston, C. M., Gannon, J. L., Kantarci, S., Krock, B. L., Zhang, S., Bayrak-Toydemir, P., & ACMG Laboratory Quality Assurance Committee (2020). Diagnostic gene sequencing panels: from design to report-a technical standard of the American College of Medical Genetics and Genomics (ACMG). Genetics in medicine : official journal of the American College of Medical Genetics, 22(3), 453–461. https://doi.org/10.1038/s41436-019-0666-z
Dbouk, M., Katona, B. W., Brand, R. E., Chak, A., Syngal, S., Farrell, J. J., Kastrinos, F., Stoffel, E. M., Blackford, A. L., Rustgi, A. K., Dudley, B., Lee, L. S., Chhoda, A., Kwon, R., Ginsberg, G. G., Klein, A. P., Kamel, I., Hruban, R. H., He, J., Shin, E. J., … Goggins, M. (2022). The Multicenter Cancer of Pancreas Screening Study: Impact on Stage and Survival. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 40(28), 3257–3266. https://doi.org/10.1200/JCO.22.00298
Karloski, E., Dudley, B., Diergaarde, B., Blanco, A., Everett, J. N., Levinson, E., Rangarajan, T., Stanich, P. P., Childers, K., Brown, S., Drogan, C., Cavestro, G. M., Gordon, K., Singh, A., Simeone, D. M., Reich, H., Kastrinos, F., Zakalik, D., Hampel, H., Pearlman, R., … Brand, R. E. (2024). The role of family history in predicting germline pathogenic variant carriers who develop pancreatic cancer: Results of a multicenter collaboration. Cancer, 130(19), 3297–3304. https://doi.org/10.1002/cncr.35383
Owens, D. K., Davidson, K. W., Krist, A. H., Barry, M. J., Cabana, M., Caughey, A. B., ... & US Preventive Services Task Force. (2019). Screening for pancreatic cancer: US preventive services task force reaffirmation recommendation statement. Jama, 322(5), 438-444. https://doi.org/10.1001/jama.2019.10232
Stoffel, E. M., McKernin, S. E., Brand, R., Canto, M., Goggins, M., Moravek, C., Nagarajan, A., Petersen, G. M., Simeone, D. M., Yurgelun, M., & Khorana, A. A. (2019). Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 37(2), 153–164. https://doi.org/10.1200/JCO.18.01489
National Comprehensive Cancer Network. (2024). Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric (version 3.2024). Retrieved from https://www.nccn.org/professionals/physician_gls/pdf/genetics_ceg.pdf
Downloads
Published
Issue
Section
License
Copyright (c) 2025 SMART-MD Journal of Precision Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Journal information